» Articles » PMID: 38405059

Lung Regeneration: Diverse Cell Types and the Therapeutic Potential

Overview
Journal MedComm (2020)
Specialty Health Services
Date 2024 Feb 26
PMID 38405059
Authors
Affiliations
Soon will be listed here.
Abstract

Lung tissue has a certain regenerative ability and triggers repair procedures after injury. Under controllable conditions, lung tissue can restore normal structure and function. Disruptions in this process can lead to respiratory system failure and even death, causing substantial medical burden. The main types of respiratory diseases are chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), and acute respiratory distress syndrome (ARDS). Multiple cells, such as lung epithelial cells, endothelial cells, fibroblasts, and immune cells, are involved in regulating the repair process after lung injury. Although the mechanism that regulates the process of lung repair has not been fully elucidated, clinical trials targeting different cells and signaling pathways have achieved some therapeutic effects in different respiratory diseases. In this review, we provide an overview of the cell type involved in the process of lung regeneration and repair, research models, and summarize molecular mechanisms involved in the regulation of lung regeneration and fibrosis. Moreover, we discuss the current clinical trials of stem cell therapy and pharmacological strategies for COPD, IPF, and ARDS treatment. This review provides a reference for further research on the molecular and cellular mechanisms of lung regeneration, drug development, and clinical trials.

Citing Articles

Preliminary proteomic analysis of mouse lung tissue treated with cyclophosphamide and Venetin-1.

Czaplewska P, Muller M, Musial N, Okroj M, Felberg-Mietka A, Sadowska J Sci Rep. 2024; 14(1):25056.

PMID: 39443613 PMC: 11499674. DOI: 10.1038/s41598-024-76143-0.


Inflammatory and Immune Mechanisms in COPD: Current Status and Therapeutic Prospects.

Qi Y, Yan Y, Tang D, Han J, Zhu X, Cui M J Inflamm Res. 2024; 17:6603-6618.

PMID: 39318994 PMC: 11421452. DOI: 10.2147/JIR.S478568.


Biomechanical Properties and Cellular Responses in Pulmonary Fibrosis.

He A, He L, Chen T, Li X, Cao C Bioengineering (Basel). 2024; 11(8).

PMID: 39199705 PMC: 11351367. DOI: 10.3390/bioengineering11080747.


Protein interactome analysis of ATP1B1 in alveolar epithelial cells using Co-Immunoprecipitation mass spectrometry and parallel reaction monitoring assay.

Zheng Y, Peng W, Wen X, Wan Q Heliyon. 2024; 10(11):e32579.

PMID: 38912441 PMC: 11193012. DOI: 10.1016/j.heliyon.2024.e32579.


Endothelial cell dynamics in sepsis-induced acute lung injury and acute respiratory distress syndrome: pathogenesis and therapeutic implications.

Qiao X, Yin J, Zheng Z, Li L, Feng X Cell Commun Signal. 2024; 22(1):241.

PMID: 38664775 PMC: 11046830. DOI: 10.1186/s12964-024-01620-y.


References
1.
Ashburn T, Thor K . Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov. 2004; 3(8):673-83. DOI: 10.1038/nrd1468. View

2.
Yang Y, Riccio P, Schotsaert M, Mori M, Lu J, Lee D . Spatial-Temporal Lineage Restrictions of Embryonic p63 Progenitors Establish Distinct Stem Cell Pools in Adult Airways. Dev Cell. 2018; 44(6):752-761.e4. PMC: 5875454. DOI: 10.1016/j.devcel.2018.03.001. View

3.
Frank D, Penkala I, Zepp J, Sivakumar A, Linares-Saldana R, Zacharias W . Early lineage specification defines alveolar epithelial ontogeny in the murine lung. Proc Natl Acad Sci U S A. 2019; 116(10):4362-4371. PMC: 6410851. DOI: 10.1073/pnas.1813952116. View

4.
Macchi F, Sadler K . Unraveling the Epigenetic Basis of Liver Development, Regeneration and Disease. Trends Genet. 2020; 36(8):587-597. DOI: 10.1016/j.tig.2020.05.002. View

5.
Singhal M, Gengenbacher N, Abdul Pari A, Kamiyama M, Hai L, Kuhn B . Temporal multi-omics identifies LRG1 as a vascular niche instructor of metastasis. Sci Transl Med. 2021; 13(609):eabe6805. PMC: 7614902. DOI: 10.1126/scitranslmed.abe6805. View